Sleep disordered breathing in patients with chronic kidney disease

Indian Journal of Medical Research

Volumn 131, Issue 2, 2010, Pages 277-284

  Mavanur, Manju ^a   Sanders, Mark ^b   Unruh, Mark ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Chronic kidney disease; End stage renal disease haemodialysis; Sleep disordered breathing

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SLEEP DISORDERED BREATHING; TREATMENT RESPONSE; UREMIA; BREATHING; CHRONIC KIDNEY FAILURE; COMORBIDITY; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; PATHOLOGY; PROCEDURES; RENAL REPLACEMENT THERAPY; RISK; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PREVALENCE; RENAL DIALYSIS; RESPIRATION; RISK; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 77649280582     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): S1-266.
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
3. Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int 2006; 70: 2131-3.
4. Shepard JW Jr. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992; 13: 437-58.
5. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003; 108: 9-12.
6. Kuhlmann U, Becker HF, Birkhahn M, Peter JH, von Wichert P, Schutterle S, et al. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 2000; 53: 460-6.
7. Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease. Am J Med 1989; 86: 308-14.
8. Kraus MA, Hamburger RJ. Sleep apnea in renal failure. Adv Perit Dial 1997; 13: 88-92.
9. Jurado-Gamez B, Martin-Malo A, Alvarez-Lara MA, Munoz L, Cosano A, Aljama P. Sleep disorders are underdiagnosed in patients on maintenance hemodialysis. Nephron Clin Pract 2007; 105: c35-42.
10. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
11. Unruh ML, Sanders MH, Redline S, Piraino BM, Umans JG, Hammond TC, et al. Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study. J Am Soc Nephrol 2006; 17: 3503-9.
12. Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu IL, Shi JM, et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 2008; 135: 710-6.
13. Iseki K, Tohyama K, Matsumoto T, Nakamura H. High prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 2008; 31: 249-55.
14. Mendelson WB, Wadhwa NK, Greenberg HE, Gujavarty K, Bergofsky E. Effects of hemodialysis on sleep apnea syndrome in end-stage renal disease. Clin Nephrol 1990; 33: 247-51.
15. Wadhwa NK, Seliger M, Greenberg HE, Bergofsky E, Mendelson WB. Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int 1992; 12: 51-6.
16. Zoccali C. Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease? Nephrol Dial Transplant 2000; 15: 1919-21.
17. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485-91.
18. Iber C, Ancoli-Israel S, Chesson A, Quan SF for the American Academy of Sleep Medicine. The AASM manual for the scoring and associated events: Rules, terminology and technical specifications, 1st ed. West Chester, Illinois: American Academy of Sleep Medicine; 2007.
19. nd ed. Diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep Medicine; 2005.
20. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
21. Beecroft JM, Zaltzman J, Prasad R, Meliton G, Hanly PJ. Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 2007; 22: 3028-33.
22. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-7.
23. Tang SC, Lam B, Ku PP, Leung WS, Chu CM, Ho YW, et al. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2607-16.
24. Unruh ML, Sanders MH, Redline S, Piraino BM, Umans JG, Chami H, et al. Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. Am J Kidney Dis 2008; 52: 305-13.
25. Beecroft J, Pierratos A, Hanly PJ. Clinical presentation of obstructive sleep apnea in patients with end-stage disease. Am J Respir Crit Care Med (in press).
26. Stepanski E, Faber M, Zorick F, Basner R, Roth T. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6: 192-7.
27. Parker KP, Bliwise DL. Clinical comparison of hemodialysis and sleep apnea patients with excessive daytime sleepiness. ANNA J 1997; 24: 663-5.
28. Jean G, Piperno D, Francois B, Charra B. Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron 1995; 71: 138-42.
29. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994; 150: 1279-85.
30. Series F, Marc I, Cormier Y, La Forge J. Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome. Ann Intern Med 1993; 119: 449-53.
31. Oeverland B, Skatvedt O, Kvaerner KJ, Akre H. Pulseoximetry: sufficient to diagnose severe sleep apnea. Sleep Med 2002; 3: 133-8.
32. Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet 1992; 339: 347-50.
33. Gyulay S, Olson LG, Hensley MJ, King MT, Allen KM, Saunders NA. A comparison of clinical assessment and home oximetry in the diagnosis of obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 50-3.
34. Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007; 3: 737-47.
35. Gay P, Weaver T, Loube D, Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006; 29: 381-401.
36. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29: 375-80.
37. Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999; 115: 863-6.
38. Shneerson J, Wright J. Lifestyle modification for obstructive sleep apnoea. Cochrane Database Syst Rev 2001; (1)(1): CD002875.
39. Pepin JL, Krieger J, Rodenstein D, Cornette A, Sforza E, Delguste P, et al. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med 1999; 160: 1124-9.
40. Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992; 145: 841-5.
41. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005; 142: 187-97.
42. Pressman MR, Benz RL, Schleifer CR, Peterson DD. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int 1993; 43: 1134-9.
43. Argekar P, Griffin V, Litaker D, Rahman M. Sleep apnea in hemodialysis patients: risk factors and effect on survival. Hemodial Int 2007; 11: 435-41.
44. Tada T, Kusano KF, Ogawa A, Iwasaki J, Sakuragi S, Kusano I, et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 2007; 22: 1190-7.
45. Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 1983; 55: 813-22.
46. Khoo MC. Determinants of ventilatory instability and variability. Respir Physiol 2000; 122: 167-82.
47. Beecroft J, Duffin J, Pierratos A, Chan CT, McFarlane P, Hanly PJ. Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 2006; 28: 151-8.
48. Chiu KL, Ryan CM, Shiota S, Ruttanaumpawan P, Arzt M, Haight JS, et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006; 174: 1378-83.
49. Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane PA, Hanly PJ. Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea. Eur Respir J 2007; 30: 965-71.
50. Tarasuik A, Heimer D, Bark H. Effect of chronic renal failure on skeletal and diaphragmatic muscle contraction. Am Rev Respir Dis 1992; 146: 1383-8.
51. Sanner BM, Tepel M, Esser M, Klewer J, Hoehmann-Riese B, Zidek W, et al. Sleep-related breathing disorders impair quality of life in haemodialysis recipients. Nephrol Dial Transplant 2002; 17: 1260-5.
52. Shayamsunder AK, Patel SS, Jain V, Peterson RA, Kimmel PL. Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patients. Semin Dial 2005; 18: 109-18.
53. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int 2003; 85 (Suppl): S105-10.
54. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA. Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant 2001; 16: 70-7.
55. Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V, Candela V, et al. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int 1998; 53: 1078-84.
56. Jung HH, Han H, Lee JH. Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 2005; 45: 875-82.
57. Turmel J, Series F, Boulet LP, Poirier P, Tardif JC, Rodes-Cabeau J, et al. Relationship between atherosclerosis and the sleep apnea syndrome: An intravascular ultrasound study. Int J Cardiol 2009; 132: 203-9.
58. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61: 2235-9.
59. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002; 17: 1518-21.
60. Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004; 65: 661-5.
61. Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane P, Hanly PJ. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 2008; 23: 673-9.
62. Beecroft JM, Duffin J, Pierratos A, Chan CT, McFarlane P, Hanly PJ. Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis. Sleep Med 2009; 10: 47-54.
63. Auckley DH, Schmidt-Nowara W, Brown LK. Reversal of sleep apnea hypopnea syndrome in end-stage renal disease after kidney transplantation. Am J Kidney Dis 1999; 34: 739-44.
64. Langevin B, Fouque D, Leger P, Robert D. Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation. Chest 1993; 103: 1330-5.
65. Eryilmaz MM, Ozdemir C, Yurtman F, Cilli A, Karaman T. Quality of sleep and quality of life in renal transplantation patients. Transplant Proc 2005; 37: 2072-6.
66. Sabbatini M, Crispo A, Pisani A, Gallo R, Cianciaruso B, Fuiano G, et al. Sleep quality in renal transplant patients: a never investigated problem. Nephrol Dial Transplant 2005; 20: 194-8.
67. Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szabo A, Mucsi I, et al. High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation - association with declining renal function. Nephrol Dial Transplant 2007; 22: 2686-92.
68. Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant 1997; 12: 1672-9.